Concourse Financial Group Securities, Inc. Medical Devices

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
MASS 908 Devices Inc.	$173M	$0 100.0% of portfolio	0	Q2 2025 New
ABT Abbott Laboratories	$228B	$0 100.0% of portfolio	0	Q2 2025 New
ARAY Accuray Inc	$100M	$0 100.0% of portfolio	0	Q2 2025 New
AHCO Adapt Health Corp.	$1.24B	$0 100.0% of portfolio	0	Q2 2025 New
ALGN Align Technology Inc	$10.7B	$0 100.0% of portfolio	0	Q2 2025 New
AHPI Allied Healthcare Products Inc	$0	$0 100.0% of portfolio	0	Q2 2025 New
ATEC Alphatec Holdings, Inc.	$2.07B	$0 100.0% of portfolio	0	Q2 2025 New
ANIK Anika Therapeutics, Inc.	$145M	$0 100.0% of portfolio	0	Q2 2025 New
APYX Apyx Medical Corp	$134M	$0 100.0% of portfolio	0	Q2 2025 New

AVNS Avanos Medical, Inc.	$529M	$0 100.0% of portfolio	0	Q2 2025 New
RCEL Avita Medical, Inc.	$93.9M	$0 100.0% of portfolio	0	Q2 2025 New
AXGN Axogen, Inc.	$1B	$0 100.0% of portfolio	0	Q2 2025 New
AZYO Aziyo Biologics, Inc.	$13.5M	$0 100.0% of portfolio	0	Q2 2025 New
XAIR Beyond Air, Inc.	$41.8M	$0 100.0% of portfolio	0	Q2 2025 New
BIO-B Bio Rad Laboratories, Inc.	$11.2B	$0 100.0% of portfolio	-	Q2 2025 New
BIO Bio Rad Laboratories, Inc.	$7.71B	$0 100.0% of portfolio	0	Q2 2025 New
BVS Bioventus Inc.	$453M	$0 100.0% of portfolio	0	Q2 2025 New
BSX Boston Scientific Corp	$147B	$0 100.0% of portfolio	0	Q2 2025 New

BWAY Brainsway Ltd.	$262M	$0 100.0% of portfolio	0	Q2 2025 New
BRKR Bruker Corp	$6.17B	$0 100.0% of portfolio	0	Q2 2025 New
BFLY Butterfly Network, Inc.	$367M	$0 100.0% of portfolio	0	Q2 2025 New
CERS Cerus Corp	$287M	$0 100.0% of portfolio	0	Q2 2025 New
CLPT Clear Point Neuro, Inc.	$379M	$0 100.0% of portfolio	0	Q2 2025 New
CODX Co Diagnostics, Inc.	$11.5M	$0 100.0% of portfolio	0	Q2 2025 New
CNMD Conmed Corp	$1.28B	$0 100.0% of portfolio	0	Q2 2025 New
AORT Artivion, Inc.	$1.84B	$0 100.0% of portfolio	0	Q2 2025 New
CVRX Cv Rx, Inc.	$187M	$0 100.0% of portfolio	0	Q2 2025 New
CTKB Cytek Biosciences, Inc.	$740M	$0 100.0% of portfolio	0	Q2 2025 New
CTSO Cytosorbents Corp	$30.5M	$0 100.0% of portfolio	0	Q2 2025 New
DCTH Delcath Systems, Inc.	$76.8M	$0 100.0% of portfolio	0	Q2 2025 New
DXCM Dexcom Inc	$22.4B	$0 100.0% of portfolio	0	Q2 2025 New
DYNT Dynatronics Corp	$743K	$0 100.0% of portfolio	0	Q2 2025 New
EAR Eargo, Inc.	$2.78B	$0 100.0% of portfolio	0	Q2 2025 New
EDAP Edap Tms Sa	$75.2M	$0 100.0% of portfolio	0	Q2 2025 New
EW Edwards Lifesciences Corp	$53.4B	$0 100.0% of portfolio	0	Q2 2025 New
ECOR Electro Core, Inc.	$399M	$0 100.0% of portfolio	0	Q2 2025 New
ELMD Electromed, Inc.	$214M	$0 100.0% of portfolio	0	Q2 2025 New
NVNO En V Veno Medical Corp	$3.98M	$0 100.0% of portfolio	0	Q2 2025 New
ESTA Establishment Labs Holdings Inc.	$1.55B	$0 100.0% of portfolio	0	Q2 2025 New
FONR Fonar Corp	$98.2M	$0 100.0% of portfolio	0	Q2 2025 New
GBS Gbs Inc.	$0	$0 100.0% of portfolio	0	Q2 2025 New
GKOS Glaukos Corp	$4.29B	$0 100.0% of portfolio	0	Q2 2025 New
GMED Globus Medical Inc	$6.51B	$0 100.0% of portfolio	0	Q2 2025 New
HYPR Hyperfine, Inc.	$66.1M	$0 100.0% of portfolio	0	Q2 2025 New
ICAD Icad Inc	$98M	$0 100.0% of portfolio	0	Q2 2025 New
ICCM Ice Cure Medical Ltd.	$26.2M	$0 100.0% of portfolio	0	Q2 2025 New
INMD In Mode Ltd.	$1.18B	$0 100.0% of portfolio	0	Q2 2025 New
INGN Inogen Inc	$158M	$0 100.0% of portfolio	0	Q2 2025 New
IINN Inspira Technologies Oxy B.H.N. LTD	$10.4M	$0 100.0% of portfolio	0	Q2 2025 New
INSP Inspire Medical Systems, Inc.	$2.49B	$0 100.0% of portfolio	0	Q2 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.